George J. Vergis

George Vergis has over 25 years in the healthcare industry serving in global leadership positions ranging from blockbuster brands at large pharmaceutical companies to research platforms at small biotechnology companies. He is currently retired and serves on several boards for not-for-profit organizations, including the Board of Choice One Crisis Pregnancy Center focused on medical, emotional and behavioral care for women and their families. He is a past board member of the Wistar Institute and former Vice-Chairman of the Board of Directors for Woods Services, LLC, a nationally recognized leader in behavioral and mental health for children and adults. Dr. Vergis most recently served as Chief Executive Officer of Neose Technologies, Inc. (NASDAQ: NTEC), a clinical stage bio-pharmaceutical company focused on next-generation therapeutic proteins. During his tenure at Neose, Dr. Vergis raised over $100 million in capital and transformed a technology platform into a fully integrated company that was successfully acquired by two of the company’s development partners. Prior to leading Neose, Dr. Vergis led New Product Development (Humira®) and the Endocrine Franchise at BASF/Knoll Pharmaceuticals (now Abbvie (NYSE: ABBV)). His career also included senior management positions in research and development, pharmaco-econоmic, marketing, sales, and new business development at Warner- Lambert Parke-Davis and Wyeth-Ayerst Laboratories (now Pfizer (NYSE: PFE)). Dr. Vergis received his undergraduate degree in Biology and History from Princeton University, his Masters in Science and Doctorate degrees in Physiology from The Pennsylvania State University, and his Masters in Business Administration from Columbia University.